Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Assets (2016 - 2025)

Traws Pharma (TRAW) has disclosed Return on Assets for 13 consecutive years, with 0.67% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 958.0% to 0.67% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.67%, a 958.0% increase, with the full-year FY2024 number at 5.98%, down 532.0% from a year prior.
  • Return on Assets was 0.67% for Q3 2025 at Traws Pharma, up from 0.8% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.29% in Q4 2021 to a low of 10.25% in Q3 2024.
  • A 5-year average of 2.15% and a median of 0.68% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: crashed -950bps in 2024, then soared 958bps in 2025.
  • Traws Pharma's Return on Assets stood at 0.29% in 2021, then crashed by -65bps to 0.47% in 2022, then crashed by -73bps to 0.82% in 2023, then tumbled by -929bps to 8.4% in 2024, then surged by 92bps to 0.67% in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Return on Assets are 0.67% (Q3 2025), 0.8% (Q2 2025), and 6.23% (Q1 2025).